Goldman Sachs Knock-Out BAX/ DE000GG7VAF5 /
2024-07-29 8:51:05 PM | Chg.-0.040 | Bid10:00:38 PM | Ask10:00:38 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.120EUR | -25.00% | - Bid Size: - |
- Ask Size: - |
Baxter International... | 36.7057 USD | 2078-12-31 | Put |
GlobeNewswire
06-26
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
06-20
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
06-20
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
06-14
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
06-12
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
06-12
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
06-04
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
05-16
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
05-15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...